Cabazitaxel versus abiraterone or enzalutamide for metastatic castration-resistant prostate cancer following docetaxel failure: a systematic review and meta-analysis
Titel:
Cabazitaxel versus abiraterone or enzalutamide for metastatic castration-resistant prostate cancer following docetaxel failure: a systematic review and meta-analysis
Auteur:
da Silva, Izael Pereira de Amorim, Lucas Guimarães Campos Roriz Piredda, Gabriel Vieira Mass-Lindenbaum, Marcelo de Moraes, Francisco Cezar Aquino Freitas, Pedro F. S. Melão, Bárbara Vieira Lima Aguiar Brandão, Helisandro Montenegro da Trindade, Karine Martins